Gaudium IVF & Women Health IPO Price: ₹75 to ₹79 per share
IPO Dates: 20th February 2026 – 24th February 2026
Company Overview
Incorporated in March 2015, Gaudium IVF and Women Health Limited is engaged in providing advanced In Vitro Fertilization (IVF) treatments across India. The company has expanded its presence in multiple states through a hub-and-spoke model, enabling wider reach and operational efficiency.
Currently, the company operates 30+ locations, including 7 hubs (centres) and 28 spokes. It has also entered into a strategic alliance with Infertility Experts (Spokes) to promote awareness and accessibility of Assisted Reproductive Technology (ART) and IVF treatments.
Gaudium IVF serves patients not only from India but also from countries such as Canada, the United Kingdom, the United States, Kenya, South Africa, and Oman, highlighting its growing international footprint.
Presence Across Major Cities
The company has established centres in key urban locations, including:
- Delhi – Janakpuri & Kailash Colony
- Mumbai – Khar West
- Ludhiana
- Srinagar
- Patna
- Bangalore
These centres ensure coverage across major regions of India.
Services Offered
Gaudium IVF provides a wide range of specialized fertility and women’s health services, including:
- In Vitro Fertilization (IVF)
- Intracytoplasmic Sperm Injection (ICSI)
- Intrauterine Insemination (IUI)
- Ovulation Induction
- Treatment for male infertility, including advanced sperm retrieval techniques
- Comprehensive gynaecological care for PCOD/PCOS and endometriosis
- High-risk pregnancy management for women with complex fertility histories or underlying health conditions
Competitive Strengths
- Patient-Centric Approach
- Experienced and Expert Medical Team
- Use of next-generation INTEGRA Ti labs for ICSI
- Highly Technical USG-Guided Services
- Established central hubs in prime urban locations such as Mumbai, Bangalore, Delhi NCR, and Patna
- Asset-Light Business Model ensuring operational efficiency and scalability
This integrated approach positions Gaudium IVF and Women Health Limited as a comprehensive fertility and women’s healthcare provider in India.
Bidding Starts In
Gaudium IVF & Women Health IPO Specifics:
| IPO Date | 20 to 24 Feb, 2026 |
| Face Value | ₹5 per share |
| Price Band | ₹75 to ₹79 per share |
| Lot Size | 189 Shares |
| Sale Type | Fresh Capital & OFS |
| Total Issue Size | 2,08,86,200 shares (agg. up to ₹165 Cr) |
| Fresh Issue | 1,13,72,222 shares (agg. up to ₹1,023 Cr) |
| Offer for Sale | 94,93,700 shares of ₹5 (agg. up to ₹75 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Share Holding Pre Issue | 6,13,94,384 shares |
| Share Holding Post Issue | 7,27,86,884 shares |
Gaudium IVF & Women Health IPO Timetable (Important Dates)
| IPO Open Date | Fri, Feb 20, 2026 |
| IPO Close Date | Tue, Feb 24, 2026 |
| Tentative Allotment | Wed, Feb 25, 2026 |
| Initiation of Refunds | Wed, Feb 25, 2026 |
| Credit of Shares to Demat | Thu, Feb 26, 2026 |
| Listing Date | Fri, Feb 27, 2026 |
Gaudium IVF & Women Health IPO Lot Size
Bidders have the opportunity to bid for a minimum of 189 shares, with the option to increase in multiples. The table below outlines the minimum and maximum investment thresholds for both retail investors and High Net Worth Individuals (HNIs), specifying the corresponding number of shares and amounts involved.
| Application | Lots | Shares | Amount |
| Retail (Min) | 1 | 189 | ₹14,931 |
| Retail (Max) | 13 | 2,457 | ₹1,94,103 |
| S-HNI (Min) | 14 | 2,646 | ₹2,09,034 |
| S-HNI (Max) | 66 | 12,474 | ₹9,85,446 |
| B-HNI (Min) | 67 | 12,663 | ₹10,00,377 |
Gaudium IVF & Women Health IPO Reservation
| QIB Shares Offered | Not more than 50.00% of the Net Issue |
| Retail Shares Offered | Not less than 35.00% of the Net Issue |
| NII (HNI) Shares Offered | Not less than 15.00% of the Net Issue |
Gaudium IVF & Women Health IPO Financial Information
| Period Ended | 30 Sep 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
| Assets | 106.62 | 88.51 | 51.01 | 36.63 |
| Total Income | 49.75 | 70.96 | 48.15 | 44.26 |
| Profit After Tax | 12.51 | 19.13 | 10.32 | 13.53 |
| EBITDA | 18.95 | 28.63 | 19.27 | 20.07 |
| NET Worth | 58.85 | 46.30 | 26.99 | 22.73 |
| Reserves and Surplus | 28.16 | 15.60 | 26.00 | 21.74 |
| Total Borrowing | 22.51 | 18.93 | 15.73 | 9.78 |
Key Performance Indicator – Gaudium IVF & Women Health IPO
| KPI | Values |
|---|---|
| ROE | 41.31% |
| ROCE | 39.70% |
| Debt/Equity | 0.41 |
| RoNW | 41.71% |
| PAT Margin | 26.96% |
| EBITDA Margin | 40.48% |
| Price to Book Value | 10.48 |
| EPS Rs | 3.12 |
| P/E (x) | 25.36 |
| Promoter Holding | 99.99% |
| Market Cap | ₹575.02 Cr. |
Prospectus Links:
Prospectus: Official documents that provide detailed information about the IPO and the company.
Gaudium IVF & Women Health IPO DRHP
Kaashika is a social media strategist and financial content creator at Lakshmishree. She specialises in simplifying complex IPO and stock market concepts into clear, easy-to-understand content. Having created over 500+ pieces of financial content across reels, blogs, website posts and digital creatives, Kaashika helps audiences connect with the world of finance in a more accessible and engaging way.
